It provides the disease confirmation or exclusion, identification of atypical Alport syndrome, determination of symptomatic and asymptomatic monoallelic COL4A3, COL4A4, and COL4A5 carriers (especially COL4A5 females), and inheritance pattern establishment. This evidence concerns the gene COL4A5 and Alport syndrome.